ERBB2 and neoplasm: The set of parameters introduced for analysis included age of the subject, menopausal status, chemotherapy regimen, number of cycles, tumor-infiltrating lymphocyte density, Ki-67 expression, nuclear grade, HER2 status, ER and PR expression, and VDR-IRS.